Hi Thrifty Clown,
Your last post was a very good précis on where we are now and head winds that we may foresee.
In relation to “ vet major “ not consummating the deal, can you respond to how you feel, that we had 8 cohort dogs in the trial. Most people scientific or otherwise would think that it would be a difficult ask on a big pharmaceutical Company to accept the limited data in a manner whereby it would be profitable to commercialise the product.
Where did we go wrong and as a Company did we think that eight again is enough, I appreciate that this number will increase, but initially it was a small number again as stated by PAA.
Can, you give us an insight on where they went wrong and why considering the impeccable credentials they have?
Cheers kpax
Hi Thrifty Clown,Your last post was a very good précis on where...
-
- There are more pages in this discussion • 45 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $97.24M | |||
| Open | High | Low | Value | Volume |
| 20.0¢ | 20.0¢ | 19.5¢ | $244.3K | 1.244M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 100000 | 19.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.0¢ | 257206 | 7 |
View Market Depth
| Last trade - 16.10pm 31/07/2024 (20 minute delay) ? |
| PAA (ASX) Chart |